Recently approved Alzheimer’s drugs offer a step forward for treating the disease, but new therapeutic strategies are needed to complement them and provide personalized therapeutic approaches. Mass General Brigham researchers have identified a potential strategy to protect against Alzheimer’s disease by increasing the clusterin protein (CLU). Their results, published in Neuron, uncover the mechanism of how increased CLU protects the brain from amyloid plaques and loss of synapses, key…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply